Ticker Scorecard - CCCC Basics Company: C4 Therapeutics, Inc. IPO Date: October 2, 2020 Sector: Healthcare Industry: Biotech Market Cap: $212.47M Activated in VL: True Average Daily Range Avg Daily Range: $0.54 | 3.80% Avg Daily Range (30 D): $0.09 | 2.64% Avg Daily Range (90 D): $0.18 | 3.81% Institutional Daily Volume Avg Daily Volume: 1.37M Avg Daily Volume (30 D): .73M Avg Daily Volume (90 D): .86M Trade Size Avg Trade Size (Sh.): 140 Avg Trade Size (Sh.) (30 D): 123 Avg Trade Size (Sh.) (90 D): 111 Institutional Trades Total Inst.Trades: 1,024 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $2.86M Avg Inst. Trade (90 D): $2.31M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.19M Avg Closing Trade (30 D): $1.43M Avg Closing Trade (90 D): $1.23M Avg Closing Volume: 176.23K     News Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight Jan 9, 2025 @ 3:53 PM NUT Midline Carcinoma Treatment Market Research Re... Source: Researchandmarkets.Com Dec 8, 2024 @ 5:30 PM C4 Therapeutics Presents Cemsidomide Phase 1 Data ... Source: N/A Nov 20, 2024 @ 12:00 PM C4 Therapeutics Appoints Accomplished Oncology Exe... Source: N/A Sep 13, 2024 @ 2:00 PM C4 Therapeutics Presents Monotherapy Data Demonstr... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.35 $-.26 $-.41 Diluted EPS $-.35 $-.26 $-.41 Revenue $ 15.36M $ 12.01M $ 3.04M Gross Profit $ $ $ Net Income / Loss $ -24.67M $ -17.72M $ -28.36M Operating Income / Loss $ -28.24M $ -21.44M $ -32.22M Cost of Revenue $ $ $ Net Cash Flow $ -13.47M $ -16.55M $ -36.93M PE Ratio